We use cookies. You have options. Cookies help us keep the site running smoothly and inform some of our advertising, but if you’d like to make adjustments, you can visit our Cookie Notice page for more information.
We’d like to use cookies on your device. Cookies help us keep the site running smoothly and inform some of our advertising, but how we use them is entirely up to you. Accept our recommended settings or customise them to your wishes.

Merkle's Pete Mehr, PhD, to Speak at DTC Performance-Based Marketing Summit

May 9, 2012
Columbia, MD

Merkle (www.merkle.com), a leading customer relationship marketing (CRM) firm and the nation’s largest privately-held agency, announces that Pete Mehr, PhD,  chief strategy officer for Merkle’s  life sciences division, will speak  at the 2nd annual DTC Performance-Based Marketing Summit. Hosted by QualityHealth, the largest and most efficient online customer acquisition solution for healthcare marketers, the summit being held May 9, 2012 at the Harvard Club in New York City, will bring together healthcare and marketing leaders for a series of discussions about marketing tactics being employed by top pharmaceutical companies and how customers are making purchasing decisions in this current economic and regulatory environment.

Mehr’s session, entitled “Synergies Matter: Driving ROI through Integrated Customer Engagement,” will take place in the late afternoon on May 9, 2012 at 3:00pm. Mehr’s session will discuss how promotion campaigns become integrated across tactics, and how engagement metrics play an increasingly important role in optimizing campaign performance & ROI. In addition, attendees will gain knowledge around the evolution of integrated campaigns across channels and customer types, gaining insight into understanding how customers engage not only with the campaign but with each other.

“The pharmaceutical industry by and large has struggled with how to promote to their different customer groups, from physicians to pharmacists to patients. Each customer type has influence in determining the course of therapy and the Rx product selected,” said Mehr. “By promoting to each customer group, pharma companies have the opportunity to recognize the value and importance of each segment in driving top-line sales and bottom-line profit. I am excited to share my insight and more importantly engage with industry leaders at this influential marketing event.”

About Merkle

Merkle, a dentsu company, is a leading data-driven customer experience management (CXM) company that specializes in the delivery of unique, personalized customer experiences across platforms and devices. For more than 30 years, Fortune 1000 companies and leading nonprofit organizations have partnered with Merkle to maximize the value of their customer portfolios. The company’s heritage in data, technology, and analytics forms the foundation for its unmatched skills in understanding consumer insights that drive hyper-personalized marketing strategies. Its combined strengths in consulting, creative, media, analytics, data, identity, CX/commerce, technology, and loyalty & promotions drive improved marketing results and competitive advantage. With more than 14,000 employees, Merkle is headquartered in Columbia, Maryland, with 50+ additional offices throughout the Americas, EMEA, and APAC. For more information, contact Merkle at 1-877-9-Merkle or visit www.merkle.com.

Media Inquiries